Neumora Therapeutics, Inc.

NMRA

Neumora Therapeutics, Inc.

NMRA

Insider Sentiment (TTM):

Last Purchase:2025-10-27Last Sale:2026-02-17Shares Purchased (TTM):5,747,100Shares Sold (TTM):138,090

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:66,272,839Shares Outstanding:179,872,000Institutional Ownership Pct.:36.84%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	117	147	183	129	125	127	142	276	151	183	374	412
Restricted Cash Current	-	-	-	0	0	1	1	1	-	-	-	-
Marketable Securities Current	-	-	-	42	93	122	165	66	221	240	80	97
Prepaid Expense And Other Assets Current	8	6	8	6	5	4	5	6	27	20	24	16
Assets Current	125	153	191	177	223	255	314	349	398	443	478	526
Marketable Securities Noncurrent	-	-	-	-	-	-	-	-	-	0	10	10
Property Plant And Equipment Net	0	0	0	0	0	1	1	1	1	2	2	2
Operating Lease Right Of Use Asset	0	0	0	0	1	1	2	3	3	4	5	6
Restricted Cash Noncurrent	-	-	-	-	-	-	0	-	1	1	1	1
Other Assets Noncurrent	0	0	0	0	0	-	-	-	-	-	-	-
Assets	125	154	191	178	224	257	317	353	404	450	496	545
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	5	3	1	1	1	3	6	1	1	0	2
Accrued Liabilities Current	23	25	29	25	20	26	25	23	18	19	21	23
Operating Lease Liability Current	0	0	0	0	0	1	2	3	4	3	3	3
Liabilities Current	28	30	32	26	21	28	30	32	23	25	25	29
Long Term Debt Noncurrent	53	53	55	20	19	-	-	-	-	-	-	-
Operating Lease Liability Noncurrent	0	0	0	0	0	-	-	-	-	1	2	3
Liabilities	81	83	87	46	41	28	30	32	23	26	27	32
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,325	1,308	1,288	1,257	1,251	1,244	1,234	1,209	1,197	1,182	1,173	1,108
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	0	-0	-0	0	0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-1,281	-1,238	-1,184	-1,125	-1,068	-1,015	-947	-888	-816	-757	-703	-595
Stockholders Equity	45	71	104	132	183	228	287	321	381	425	469	513
Liabilities And Stockholders Equity	125	154	191	178	224	257	317	353	404	450	496	545
Preferred Stock Par Or Stated Value Per Share	-	-	0	-	-	-	0	-	-	-	0	-
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	-	-	-	-	0	-
Preferred Stock Shares Authorized	-	-	50	-	-	-	50	-	-	-	50	-
Preferred Stock Shares Issued	-	-	0	-	-	-	0	-	-	-	0	-
Temporary Equity Shares Authorized	-	-	-	-	-	-	-	-	-	-	50	-
Temporary Equity Shares Issued	-	-	-	-	-	-	-	-	-	-	0	-
Preferred Stock Shares Outstanding	-	-	0	-	-	-	0	-	-	-	0	-
Temporary Equity Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Shares Authorized	-	-	700	-	-	-	700	-	-	-	700	-
Common Stock Shares Issued	-	-	174	-	-	-	162	-	-	-	159	-
Shares Outstanding	-	-	174	-	-	-	162	-	-	-	159	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-4.64%	-15.46%	-23.20%	-	-	-	-	-	-	-	-	-
2025	47.19%	18.61%	125.11%	8.81%	9.43%	65.41%	-13.18%	-31.01%	-20.16%	16.58%	-4.15%	-21.76%
2024	0.92%	0.20%	31.50%	-4.09%	7.76%	2.34%	-9.02%	-80.81%	-82.94%	-26.69%	-46.05%	-51.60%
2023	-	-	-	-	-	-	10.47%	62.19%	32.07%	-27.63%	-51.84%	-51.74%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.50	5.09	5.87	6.85	10.54	8.98	10.51	10.98	17.22	17.99	19.05	18.05
Quick Ratio	4.21	4.88	5.62	6.64	10.28	8.83	10.33	10.79	16.07	17.18	18.08	17.50
Working Capital	97.10M	123.32M	158.09M	151.24M	201.75M	226.48M	284.17M	316.87M	375.19M	418.18M	453.17M	496.61M
Leverage & Debt
Debt to Equity	1.81	1.18	0.84	0.35	0.22	0.12	0.10	0.10	0.06	0.06	0.06	0.06
Interest Coverage TTM	-32.71	-43.97	-38.32	-29.43	-22.41	-16.48	-13.22	-13.83	-13.31	-	-	-
Debt Ratio	0.64	0.54	0.46	0.26	0.18	0.11	0.09	0.09	0.06	0.06	0.05	0.06
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Per Share Metrics
Diluted EPS TTM	-1.15	-1.24	-1.45	-1.46	-1.56	-1.60	-1.53	-2.31	-2.19	-	-	-
Free Cash Flow Per Share TTM	-1.05	-1.08	-1.26	-0.92	-0.84	-1.24	-1.15	-1.15	-1.65	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Growth Metrics
Net Income Growth (1Y)	-15.61%	-13.82%	-2.81%	-35.77%	-27.63%	-	-	-	-	-	-	-
EPS Growth (1Y)	-26.31%	-22.65%	-5.20%	-36.66%	-28.84%	-	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-1.48	-1.58	-1.23	-1.25	-0.47	-0.63	-6.93	-5.73	-4.49	-	-	-
P/B TTM	7.07	4.96	2.82	2.23	0.65	0.71	5.89	6.57	4.10	5.12	2.36	1.28
Market Cap	314.78M	350.75M	292.47M	294.55M	118.52M	161.45M	1.69B	2.11B	1.56B	2.17B	1.11B	658.81M
Enterprise Value	250.86M	256.64M	164.47M	185.04M	13.45M	34.59M	1.55B	1.83B	1.41B	1.99B	734.57M	246.53M
Calculated Values
Free Cash Flow TTM	-193.58M	-193.41M	-206.46M	-149.39M	-136.23M	-199.43M	-182.94M	-184.16M	-262.58M	-	-	-
Net Debt	-63.92M	-94.11M	-128.00M	-109.51M	-105.07M	-126.86M	-142.15M	-275.71M	-150.68M	-182.93M	-374.04M	-412.28M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-17Sale

Owner: Milligan, Michael Lee

Title: See Remarks

Shares: 1,436

Price/Share: $3.57

Value: $5,126.52

Shares Owned: 21,034

Relationship: Officer

Ownership: Direct

2026-02-17Sale

Owner: Aurora, Daljit Singh

Title: See Remarks

Shares: 6,165

Price/Share: $3.56

Value: $21,947.40

Shares Owned: 82,770

Relationship: Officer

Ownership: Direct

2026-02-17Sale

Owner: Pinto, Joshua

Title: President

Shares: 5,967

Price/Share: $3.54

Value: $21,123.18

Shares Owned: 57,783

Relationship: Officer

Ownership: Direct

2026-02-17Sale

Owner: Berns, Paul L

Title: See Remarks

Shares: 9,819

Price/Share: $3.51

Value: $34,464.69

Shares Owned: 7,395,185

Relationship: Director,Officer

Ownership: Direct

2025-11-11Sale

Owner: Aurora, Daljit Singh

Title: See Remarks

Shares: 114,703

Price/Share: $2.68

Value: $307,404.04

Shares Owned: -

Relationship: Officer

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-17	Milligan, Michael Lee	Officer	See Remarks	Direct	Sale	1,436	3.57	$5,126.52	21,034	4
2026-02-17	Aurora, Daljit Singh	Officer	See Remarks	Direct	Sale	6,165	3.56	$21,947.40	82,770	4
2026-02-17	Pinto, Joshua	Officer	President	Direct	Sale	5,967	3.54	$21,123.18	57,783	4
2026-02-17	Berns, Paul L	Director,Officer	See Remarks	Direct	Sale	9,819	3.51	$34,464.69	7,395,185	4
2025-11-11	Aurora, Daljit Singh	Officer	See Remarks	Indirect	Sale	114,703	2.68	$307,404.04	0	4
2025-10-27	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	1,915,700	2.61	$4,999,977.00	6,046,907	4
2025-10-27	Arch, Venture Partners Vi…	TenPercentOwner	-	Indirect	Purchase	1,915,700	2.61	$4,999,977.00	6,046,907	4
2025-10-27	Arch, Venture Partners Xi…	TenPercentOwner	-	Indirect	Purchase	1,915,700	2.61	$4,999,977.00	6,046,907	4
2025-02-18	Aurora, Daljit Singh	Officer	Chief Strategy Officer	Direct	Sale	8,565	1.68	$14,389.20	88,935	4
2025-02-18	Lenz, Robert A.	Officer	Head of R&D	Direct	Sale	5,614	1.67	$9,375.38	309,092	4
2025-02-18	Pinto, Joshua	Officer	President	Direct	Sale	8,048	1.67	$13,440.16	76,952	4
2025-02-18	Milligan, Michael Lee	Officer	See Remarks	Direct	Sale	1,978	1.69	$3,342.82	22,470	4
2025-02-18	Berns, Paul L	Director,Officer	See Remarks	Direct	Sale	13,871	1.69	$23,441.99	7,405,004	4
2024-10-18	Fust, Matthew K	Director	-	Direct	Sale	14,049	17.03	$239,254.47	20,100	4
2024-10-10	Lenz, Robert A.	Officer	Head of R&D	Direct	Sale	8,260	15.09	$124,643.40	314,706	4
2024-09-18	Lenz, Robert A.	Officer	Head of R&D	Direct	Sale	10,676	12.09	$129,072.84	328,529	4
2024-09-12	Lenz, Robert A.	Officer	Head of R&D	Direct	Sale	32,948	11.43	$376,595.64	369,993	4
2024-08-27	Pinto, Joshua	Officer	Chief Financial Officer	Indirect	Sale	15,693	11.39	$178,743.27	138,965	4
2024-08-26	Pinto, Joshua	Officer	Chief Financial Officer	Indirect	Sale	31,642	11.78	$372,742.76	154,658	4
2023-11-14	Arch, Venture Fund Xii, L…	TenPercentOwner	-	Indirect	Purchase	3,357	11.98	$40,216.86	4,131,207	4
2023-11-14	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	3,357	11.98	$40,216.86	4,131,207	4
2023-11-10	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	17,275	11.56	$199,699.00	4,096,197	4
2023-11-10	Arch, Venture Fund Xii, L…	TenPercentOwner	-	Indirect	Purchase	17,275	11.56	$199,699.00	4,096,197	4
2023-11-07	Arch, Venture Partners Xi…	TenPercentOwner	-	Indirect	Purchase	30,192	11.50	$347,208.00	3,955,592	4
2023-11-07	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	30,192	11.50	$347,208.00	3,955,592	4
2023-09-29	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	34,560	13.98	$483,148.80	3,859,898	4
2023-09-29	Nelsen, Robert, Arch Vent…	TenPercentOwner	-	Indirect	Purchase	34,560	13.98	$483,148.80	3,859,898	4
2023-09-27	Nelsen, Robert, Gillis St…	TenPercentOwner	-	Indirect	Purchase	24,504	12.31	$301,644.24	3,783,387	4
2023-09-27	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	24,504	12.31	$301,644.24	3,783,387	4
2023-09-25	Nelsen, Robert, Arch Vent…	TenPercentOwner	-	Indirect	Purchase	60,740	11.23	$682,110.20	3,724,883	4
2023-09-25	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	60,740	11.23	$682,110.20	3,724,883	4
2023-09-19	Nelsen, Robert, Arch Vent…	TenPercentOwner	-	Indirect	Purchase	1,500,000	17.00	$25,500,000.00	3,624,143	4
2023-09-19	Burow, Kristina	Director,TenPercentOwner	-	Indirect	Purchase	1,500,000	17.00	$25,500,000.00	3,624,143	4
2023-09-19	Gosebruch, Henry O	Director,Officer	President & CEO	Indirect	Purchase	15,000	12.62	$189,300.00	15,000	4
2023-09-19	Amgen, Inc	TenPercentOwner	-	Direct	Purchase	1,764,705	17.00	$29,999,985.00	35,368,653	4
2023-09-19	Arch, Venture Partners Vi…	TenPercentOwner	-	Indirect	Purchase	1,500,000	17.00	$25,500,000.00	3,624,143	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

36.84%

Inst. Shares: 66,272,839

Shares Outstanding: 179,872,000

2025-12-31

37.88%

Inst. Shares: 61,899,184

Shares Outstanding: 163,391,000

2025-09-30

29.85%

Inst. Shares: 48,301,680

Shares Outstanding: 161,838,000

2025-06-30

30.94%

Inst. Shares: 50,021,274

Shares Outstanding: 161,691,000

2025-03-31

37.36%

Inst. Shares: 60,325,393

Shares Outstanding: 161,451,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	66,272,839	179,872,000	36.84%
2025-12-31	61,899,184	163,391,000	37.88%
2025-09-30	48,301,680	161,838,000	29.85%
2025-06-30	50,021,274	161,691,000	30.94%
2025-03-31	60,325,393	161,451,000	37.36%
2024-12-31	72,682,903	159,377,000	45.60%
2024-09-30	62,209,689	159,576,000	38.98%
2024-06-30	57,614,745	158,984,000	36.24%
2024-03-31	45,425,981	157,943,000	28.76%
2023-12-31	41,098,700	65,021,000	63.21%
2023-09-30	31,272,918	46,691,000	66.98%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Neumora Therapeutics, Inc. (NMRA) — SEC Financial Statements & Analysis

Neumora Therapeutics, Inc. (NMRA) is a biological products, (no diagnostic substances) company, incorporated in DE. Neumora Therapeutics, Inc. trades on Nasdaq as: NMRA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Neumora Therapeutics, Inc. reported a Debt-to-Equity ratio of 1.81x, a Price-to-Book (P/B) ratio of 7.07x (TTM), at a market cap of $314.78M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 1.81x
P/B TTM: 7.07x
Market Cap: $314.78M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Neumora Therapeutics, Inc. in?

Neumora Therapeutics, Inc. (NMRA) operates in the Biological Products, (No Diagnostic Substances) industry.

What is NMRA's market cap?

Neumora Therapeutics, Inc. (NMRA) has a market capitalization of $314.78M as of 2026-06-30.

What exchange does NMRA trade on?

Neumora Therapeutics, Inc. (NMRA) trades on the Nasdaq.

Where is Neumora Therapeutics, Inc. incorporated?

Neumora Therapeutics, Inc. is incorporated in DE.